Screening assays for compounds

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 723, 435 724, 435 794, 435 15, 435 21, 435 29, 436518, 436548, G01N 33543

Patent

active

057631980

ABSTRACT:
The invention is directed to rapid and quantitative assay systems for screening test compounds for their ability to modulate tyrosine kinase or phosphatase activities involved in signal transduction by determining the tyrosine phosphorylation state of a protein substrate using an anti-phosphotyrosine antibody and an antibody specific for the protein substrate. These assays may be practiced in a whole cell or cell-free system. The assays can be used to identify test compounds for use in therapeutic applications to disease processes in which tyrosine kinase or phosphatase activity in a signal transduction pathway contributes to a pathological process.

REFERENCES:
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4478946 (1984-10-01), Van der Merwe et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5427916 (1995-06-01), Gerwitz et al.
patent: 5527688 (1996-06-01), Millia
patent: 5538858 (1996-07-01), Mallia
patent: 5580742 (1996-12-01), Bodenmuller et al.
patent: 5599681 (1997-02-01), Epstein et al.
Millauer et al., 1994, "Glioblastoma Growth Inhibited in vivo by a Dominant-Negative Flk-1 Mutant," Nature 367:576-579.
Fu et al., 1993, "Transcription Factor p91 Interacts with the Epidermal Growth Factor Receptor and Mediates Activation of the c-fos Gene Promoter," Cell 74:1135-1145.
Musacchio et al., 1993, "The PH Domain: a Common Piece in the Structural Patchwork of Signalling Proteins," TBIS 18:343-348.
Katagiri et al., 1993, "Tyrosine-Phosphorylation of Tubulin during Nonocytic Differentiation of HL-60 Cells," J. Immunol. 150:585-593.
Schraag et al., 1993, "Standardization of an Enzyme-Linked Immunosorbent Assay for the Determination of Protein Tyrosine Kinase Activity," Analytical Biochem. 211:233-239.
Walton et al., 1993, "Protein Tyrosine Phosphatases," Annu. Rev. Biochem. 62:101-20.
Pawson et al., 1993, "SH2 and SH3 Domains," Current Biology 3:434-442.
Hansen et al., 1993, "Application of Two-Dimensional Gel Analysis to Identification and Characterization of Tyrosine Phosphorylated Substrates for Growth Factors Receptors," Electrophoresis 14:112-126.
Campbell et al., 1993, "Evidence for Involvement of the Growth Hormone Receptor-Associated Tyrosine Kinase in Actions of Growth Hormone," J. Biol. Chem. 268:7427-7434.
Pawson et al., 1992, "SH2 and SH3 Domains: From Structure to Function," Cell 71:359-362.
Schlessinger et al., 1992, "Growth Factor Signalling by Receptor Tyrosine Kinases," Neuron 9:383-391.
Pelicci et al., 1992, "A Novel Transforming Protein (SHC) with an SH2 Domain is Implicated in Mitogenic Signal Transduction," Cell 70:93-104.
Farley et al., 1992, "Development of Solid-Phase Enzyme-Linked Immunosorbent Assays for the Determination of Epidermal Growth Factor Receptor and pp60.sup.c-src Tyrosine Protein Kinase Activity," Analytical Biochem. 203:151-157.
Peraldi et al., 1992, "Dephosphorylation of Human Insulin-Like Growth Factor I (IGF-I) Receptors by Membrane-Associated Tyrosine Phosphatases," Biochem J. 285:71-78.
Koch et al., 1991, "SH2 and SH3 Domains: Elements That Control Interactions of Cytoplasmic Signaling Proteins," Science 252:668-674.
Donato et al., 1991, "Tumor Necrosis Factor Regulates Tyrosine Phosphorylation on Epidermal Growth Factor Receptors in A431 Carcinoma Cells: Evidence for a Distinct Mechanism," Cell Growth & Differentiation 3:259-268.
Aaronson et al., 1991, "Growth Factors and Cancer," Science 254:1146-1153.
Ueno et al., 1991, "Inhibition of PDGF .beta. Receptor Signal Transduction by Coexpression of a Truncated Receptor," Science 252:844-848.
Skolinik et al., 1991, "Cloning of P13 Kinase-Associated p85 Utilizing a Novel Method for Expression/Cloning of Target Proteins for Receptor Tyrosine Kinases," Cell 65:83-90.
Cantley et al., 1991, "Oncogenes and Signal Transduction," Cell 64:281-302.
Lazaro et al., 1991, "Description of an Enzyme-Linked Immunosorbent Assay for the Detection of Protein Tyrosine Kinase," Analytical Biochem. 192:257-261.
Tonks et al., 1991, "Purification of Protein-Tyrosine Phosphatases from Human Placenta," Methods in Enzymology 201:427-442.
Bjorge et al., 1990, "Activated Type 1 Phosphatidylinositol Kinase is Associated with the Epidermal Growth Factor (EGF) Receptor Following EGF Stimulation," Biochemistry 87:3816-3820.
Ullrich et al., 1990, "Signal Transduction by Receptors with Tyrosine Kinases Activity," Cell 61:203-212.
Fendly et al., 1990, "Characterization of Murine Monoclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2
eu Gene Product," Cancer Research 50:1550-1558.
Cleaveland et al., "A Microtiter-Based Assay for the Detection of Protein Tyrosine Kinase Activity," Analytical Biochem. 190:249-253.
Rijksen et al., 1989, "A Nonradioactive Dot-Blot Assay for Protein Kinase Activity," Analytical Biochem. 182:98-102.
Huse et al., "Generation of a Large Combination Library of the Immunoglobulin Repertoire in Phage Lambda," Science 246:1275-1281.
Margolis et al., 1989, "EGF Induces Tyrosine Phosphorylation of Phospholipase C-II: A Potential Mechanism for EGF Receptor Signalling," Cell 57:1101-1107.
Van Heede et al., 1989, "Expression of Human Asparagine Synthetase in Escherichia coli," J. Biol. Chem. 264:5503-5509.
Drebin et al., 1989, "Monoclonal Antibodies Specific for the neu Oncogene Product Directly Mediate Anti-Tumor Effects in vivo," Oncogene 2:387-394.
Schlessinger, J., 1988, "Signal Transduction by Allosteric Receptor Oligomerization," TIBS 13:443-447.
Harlow & Lane ed., 1988, "Storing and Purifying Antibodies," (in Antibodies: A Laboratory Manual, Cold Springs Harbor Laboratory Press) 283-318.
Honegger et al., 1987, "Point Mutation at the ATP Binding Site of EGF Receptor Abolishes Protein-Tyrosine Kinase Activity and Alters Cellular Routing," Cell 51:199-209.
Slamon et al., 1987, "Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2
eu Oncogene," Science 235:177-182.
Bitter et al., 1987, "Expression and Secretion Vectors for Yeast," Methods in Enzymology 153:516-544.
Takeda et al., 1985, "Construction of Chimaeric Processed Immunoglobulin Genes Containing Mouse Variable and Human Constant Region Sequences," Nature 314:452-454.
Cole et al., 1985, "The EBV-Hybridoma Technique and Its Application to Human Lung Cancer," (in Monoclonal Antibodies and Cancer Therapy, Albert R. Liss Inc.) 77-96.
Inouye et al., 1985, "Up-Promoter Mutations in the Ipp Gene of Escherichia coli," Nucleic Acids Research 13:3101-3110.
Neuberger et al., 1984, "Recombinant Antibodies Possessing Novel Effector Functions," Nature 312:604-608.
Morrison et al., 1984, "Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains with Human Constant Region Domains," Proc. Natl. Acad. Sci. USA 81:6851-6855.
Logan et al., 1984, "Adenovirus Tripartite Leader Sequence Enhances Translation of mRNA Late After Infection," Proc. Natl. Acad. Sci. USA 81:3655-3659.
Smith et al., 1983, "Molecular Engineering of the Autographa Californica Nuclear Polyhedrosis Virus Genome: Deletion Mutations Within the Polyhedrin Gene," J. Virology 46:584-593.
Cote et al., 1983, "Generation of Human Monoclonal Antibodies Reactive with Cellular Antigens," Proc. Natl. Acad. Sci. USA 80:2026-2030.
Ruther et al., 1983, "Easy Identification of cDNA Clones," EMBO 2:1791-1794.
Kozbor et al., 1983, "The Production of Monoclonal Antibodies from Human Lymphocytes," Immunol. Today 4:72-79.
Tsang et al., 1983, "Enzyme-Linked Immunoelectrotransfer Blot Techniques (EITB) for Studying the Specificities of Antigens and Antibodies Separated by Gel Electorphoresis," Methods in Enzymology 92:377-391.
Kohler et al., 1975, "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity," Nature 256:495-497.
Gazit et al., 1991, "Tyrphostins. 2. Heterocyclic and .alpha.-substituted benzylidenemalonitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2
eu tyrosine kinases", J Med Chem 34:1896-1907.
Ohmichi et al., 1993, "The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor", Biochemistry 32:4650-4658.
Creighton, 1984, in Proteins: Stru

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Screening assays for compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening assays for compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assays for compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2197748

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.